title: Management of metastatic castration-resistant prostate cancer: Insights from urology experts in Thailand.
abstract: Treatment options for castration-resistant prostate cancer (CRPC) are available, but clear instructions for the selection of appropriate treatment are lacking. A meeting of urology experts based in Thailand was convened with the following objectives: (1) to reach a consensus and share real-life experiences about how to identify CRPC; (2) to choose the appropriate treatment for CRPC patients; (3) to evaluate disease progression using novel inhibitors of the androgen receptor pathway; (4) to identify the frequency of monitoring disease; and (5) to promote rational use of corticosteroids in CRPC patients. This consensus document can provide guidance to other urologists in Thailand to provide appropriate treatment to metastatic CRPC patients in a timely manner.
authors.affiliation: Division of Urology, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
authors.forename: Bannakij
authors.initials: B
authors.lastname: Lojanapiwat
authors.affiliation: Urological Unit, Department of Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
authors.forename: Choosak
authors.initials: C
authors.lastname: Pripatnanont
authors.affiliation: Division of Urology, Department of Surgery, Rajavithi Hospital, Bangkok, Thailand.
authors.forename: Vorapot
authors.initials: V
authors.lastname: Choonhaklai
authors.affiliation: Division of Urology, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
authors.forename: Surithorn
authors.initials: S
authors.lastname: Soontornpun
authors.affiliation: Division of Urology, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
authors.forename: Supon
authors.initials: S
authors.lastname: Sriplakich
authors.affiliation: Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand.
authors.forename: Sunai
authors.initials: S
authors.lastname: Leewansangtong
authors.affiliation: Division of Urology, Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
authors.forename: Apirak
authors.initials: A
authors.lastname: Santi-Ngamkun
authors.affiliation: Division of Urology, Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
authors.forename: Julin
authors.initials: J
authors.lastname: Opanuraks
authors.affiliation: Division of Urology, Department of Surgery, Ramathibodi Hospital, Bangkok, Thailand.
authors.forename: Wisoot
authors.initials: W
authors.lastname: Kongcharoensombat
authors.affiliation: Division of Urology, Department of Surgery, Faculty of Medicine, Navamindrathiraj University, Bangkok, Thailand.
authors.forename: Bhapapak
authors.initials: B
authors.lastname: Na-Songkla
authors.affiliation: Division of Urology, Department of Surgery, Faculty of Medicine, Navamindrathiraj University, Bangkok, Thailand.
authors.forename: Wiroj
authors.initials: W
authors.lastname: Raksakul
authors.affiliation: Urological Unit, Department of Surgery, Khon Kaen Hospital, Khon Kaen, Thailand.
authors.forename: Chagkrapan
authors.initials: C
authors.lastname: Predanon
keywords: Abiraterone acetate; Androgen receptor; Metastatic castration-resistant prostate cancer; Prostate-specific antigen; Urology expert